- Presentations
- 6
- Markets
- 1
Abilify is a brand of Aripiprazole marketed by Otsuka America Pharmaceutical, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Aripiprazole
- Brand owner
- Otsuka America Pharmaceutical
- Registered in
- United States
- Strengths and forms
- 10 mg tablet, 15 mg tablet, 2 mg tablet, 20 mg tablet, 30 mg tablet, 5 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Abilify 10 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Abilify 15 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Abilify 2 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Abilify 20 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Abilify 30 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
| Abilify 5 mg tabletOral | Otsuka America Pharmaceutical | US FDA | Available on request |
Equivalent brands
Other brands of Aripiprazole.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Abilify
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.